CME/CE

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Douglas Devries Faculty: Cecelia Koetting Demodex blepharitis (DB) is a common yet frequently underrecognized condition, often misdiagnosed as dry eye disease or meibomian gland dysfunction, leading to delayed treatment and increased patient burden. Clinicians need improved recognition of hallmark signs such as collarettes, along with a clearer understanding of the limitations of traditio...

Faculty: Cem Akin, MD, PhD This online CME activity explores the clinical complexity and real-world impact of systemic mastocytosis through both clinician insight and patient experience. Participants will examine the multisystem burden of this disease, challenges in diagnosis, and the importance of recognizing symptoms that are often underestimated. The program reviews current evidence-based and t...

Faculty: Cem Akin, MD, PhD This online CME activity explores the clinical complexity and real-world impact of systemic mastocytosis through both clinician insight and patient experience. Participants will examine the multisystem burden of this disease, challenges in diagnosis, and the importance of recognizing symptoms that are often underestimated. The program reviews current evidence-based and t...

Faculty: Harry Erba, MD, PhD This educational series explores evolving strategies in the management of acute myeloid leukemia (AML) with a focus on targeted therapies. Faculty experts will review molecular diagnostics and guideline-driven use of FLT3 and menin inhibitors across treatment lines, including frontline, relapsed/refractory, and maintenance settings. Participants will examine clinical t...

Faculty: Harry Erba, MD, PhD This educational series explores evolving strategies in the management of acute myeloid leukemia (AML) with a focus on targeted therapies. Faculty experts will review molecular diagnostics and guideline-driven use of FLT3 and menin inhibitors across treatment lines, including frontline, relapsed/refractory, and maintenance settings. Participants will examine clinical t...

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Guest: Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC Guest: Pam R. Taub, MD, FACC, FASPC On-demand webcast covering the latest advances in lipid management and atherosclerotic cardiovascular disease risk reduction, including the emerging role of lipoprotein(a), data on novel lipid-lowering the...

Faculty: Cecelia Koetting, OD, FAAO Faculty: Lisa Hornick, OD, MBA, FAAO Faculty: Katherine Rachon, OD, FAAO Neurotrophic keratitis (NK) remains significantly underdiagnosed because early findings are easily mistaken for dry eye disease and other ocular surface disorders. Although reduced corneal sensitivity is the defining feature of NK, corneal sensitivity testing is not routinely performed, res...

Faculty: Walter O. Whitley, OD, FAAO Faculty: Nate Lighthizer, OD, FAAO, FAAOMS Faculty: Jessica Steen, OD, FAAO, Dipl-ABO Glaucoma care is shifting from a narrow focus on pressure targets to a broader, patient-centered approach that balances durable intraocular pressure (IOP) control with preservation of the ocular surface, comfort, and real-world adherence. But, daily practice often still defaul...

Faculty: Cecelia Koetting, OD, FAAO Faculty: Lisa Hornick, OD, MBA, FAAO Faculty: Katherine Rachon, OD, FAAO Neurotrophic keratitis (NK) remains significantly underdiagnosed because early findings are easily mistaken for dry eye disease and other ocular surface disorders. Although reduced corneal sensitivity is the defining feature of NK, corneal sensitivity testing is not routinely performed, res...

Faculty: Walter O. Whitley, OD, FAAO Faculty: Nate Lighthizer, OD, FAAO, FAAOMS Faculty: Jessica Steen, OD, FAAO, Dipl-ABO Glaucoma care is shifting from a narrow focus on pressure targets to a broader, patient-centered approach that balances durable intraocular pressure (IOP) control with preservation of the ocular surface, comfort, and real-world adherence. But, daily practice often still defaul...

Faculty: Roger A. Goldberg, MD, MBA Faculty: Christina Y. Weng, MD, MBA, FASRS Faculty: Yasha S. Modi, MD, MHS Current guidelines recommend the use of second-generation therapies for the treatment of retinal diseases; however, limited head-to-head study data make it difficult to determine which strategies to use for specific patients and at what time. In this activity, experts in the field of reti...

Faculty: Roger A. Goldberg, MD, MBA Faculty: Christina Y. Weng, MD, MBA, FASRS Faculty: Yasha S. Modi, MD, MHS Current guidelines recommend the use of second-generation therapies for the treatment of retinal diseases; however, limited head-to-head study data make it difficult to determine which strategies to use for specific patients and at what time. In this activity, experts in the field of reti...

Faculty: Deepak Sambhara, MD This rebroadcast of a live regional meeting series, part of The Focused Sight Initiative: Quality Improvement Interventions in Retinal Diseases, brings together retina specialists and eye care professionals to address systemic gaps in the timely diagnosis, referral, and management of patients with retinal diseases, including age-related macular degeneration (AMD), diab...

Faculty: Deepak Sambhara, MD This rebroadcast of a live regional meeting series, part of The Focused Sight Initiative: Quality Improvement Interventions in Retinal Diseases, brings together retina specialists and eye care professionals to address systemic gaps in the timely diagnosis, referral, and management of patients with retinal diseases, including age-related macular degeneration (AMD), diab...

Host: Leandra A. Barnes, MD Guest: Mikael Horissian, MD, MBA Guest: Katrina H. Lee, MD Guest: Venessa Peña-Robichaux, MD On-demand webcast on the pathophysiology of hidradenitis suppurativa (HS), best practices for its timely diagnosis and long-term management, and the latest data on emerging therapies.

Faculty: John E. Anderson, MD Faculty: Davida F. Kruger, CNP Continuous glucose monitoring (CGM) has been widely used in individuals with type 1 diabetes (T1D), and evolving guidelines increasingly recommend its use for those with type 2 diabetes (T2D) as well. However, despite these updated recommendations, real-world adoption to support T2D management has remained lower than expected. Before exp...

Faculty: John E. Anderson, MD Faculty: Davida F. Kruger, CNP Continuous glucose monitoring (CGM) has been widely used in individuals with type 1 diabetes (T1D), and evolving guidelines increasingly recommend its use for those with type 2 diabetes (T2D) as well. However, despite these updated recommendations, real-world adoption to support T2D management has remained lower than expected. Before exp...

Faculty: Richard Lafayette, MD, FACP Faculty: Ankana Daga, MD Complement-mediated kidney diseases such as C3 glomerulopathy (C3G) continue to present significant diagnostic and therapeutic challenges in nephrology for both adult and pediatric patients. Among children, this rare disease can progress to end-stage kidney disease within 10 years of diagnosis. Traditional treatment options include supp...

Faculty: Richard Lafayette, MD, FACP Faculty: Ankana Daga, MD Complement-mediated kidney diseases such as C3 glomerulopathy (C3G) continue to present significant diagnostic and therapeutic challenges in nephrology for both adult and pediatric patients. Among children, this rare disease can progress to end-stage kidney disease within 10 years of diagnosis. Traditional treatment options include supp...

Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Guest: Stephen J. Greene, MD, FACC, FHFSA Guest: Anne Louise Peters, MD On-demand webcast on best practices for optimizing guideline-directed medical therapy in cardiovascular-renal-metabolic (CRM) care and employing SGLT2 inhibitors to treat patients with CRM conditions, including heart failure.